Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-29 @ 8:29 PM
Study NCT ID:
NCT04416035
Status:
UNKNOWN
Last Update Posted:
2020-08-31
First Post:
2020-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC
Sponsor:
Zhejiang Teruisi Pharmaceutical Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-11-10
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-01
First Submit QC Date:
None
Study First Post Date:
2020-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-27
Last Update Post Date:
2020-08-31
Last Update Post Date Type:
ACTUAL